Nucleai
Ron Elran has extensive work experience in various roles and industries. Ron began their career at zo-opt in 2007, where they served as the Marketing Manager R&D and Director until 2012. In 2020, they joined MyHeritage as a lab associate in the COVID-19 analysis team. Ron worked in this role until 2021 when they transitioned to Nucleai as a Medical Data Specialist.
Ron Elran completed their Bachelor of Science degree in Marine Sciences at Ruppin Academic Center from 1999 to 2003. Ron then went on to pursue a Master of Science degree in Marine Sciences at the University of Haifa, which they completed from 2012 to 2015. Following this, they obtained a Doctor of Philosophy (PhD) degree in Microbial and Eukaryotic Genetics from Technion - Israel Institute of Technology, where they were enrolled from 2015 to 2019.
Nucleai
7 followers
Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies,licensing its research platform for internal use, and collaborating in biomarkers discovery projects.